Segall Bryant & Hamill, LLC Procept Bio Robotics Corp Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 168,882 shares of PRCT stock, worth $9.12 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
168,882
Previous 142,039
18.9%
Holding current value
$9.12 Million
Previous $11.4 Million
13.96%
% of portfolio
0.16%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
288Shares Held
38.8MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$277 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$188 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$94.6 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$65.2 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$64.2 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.41B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...